Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A12975 | 30200724 | Zhongguo Zhong Yao Za Zhi | [Effect of traditional Chinese medicine in inhibiting obesity and inflammatory diseases by regulating gut microbiota]. | 2018 | Details |
| A12976 | 30200715 | Zhongguo Zhong Yao Za Zhi | [Effect of Fuzi Lizhong decoction in reducing liver injury of rats with non-alcoholic fatty liver via activating AMPK and suppressing NF-κBp65 pathway]. | 2018 | Details |
| A12977 | 30200543 | Nutrients | Tomato Juice Supplementation Influences the Gene Expression Related to Steatosis in Rats. | 2018 | Details |
| A12978 | 30200408 | Nutrients | Muscle Loss in Chronic Liver Diseases: The Example of Nonalcoholic Liver Disease. | 2018 | Details |
| A12979 | 30198086 | J Sci Food Agric | Dietary salmon milt extracts attenuate hepatosteatosis and liver dysfunction in diet-induced fatty liver model. | 2018 | Details |
| A12980 | 30197624 | Front Endocrinol (Lausanne) | Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches. | 2018 | Details |
| A12981 | 30197529 | Clin Exp Gastroenterol | Liver function tests in identifying patients with liver disease. | 2018 | Details |
| A12982 | 30197519 | Ther Clin Risk Manag | Epicardial adipose tissue volume is associated with non-alcoholic fatty liver disease and cardiovascular risk factors in the general population. | 2018 | Details |
| A12983 | 30197273 | J Clin Lipidol | Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study. | 2018 | Details |
| A12985 | 30196282 | Cell Physiol Biochem | Ganoderma Lucidum Polysaccharide Peptide Alleviates Hepatoteatosis via Modulating Bile Acid Metabolism Dependent on FXR-SHP/FGF. | 2018 | Details |
| A12986 | 30196156 | Clin Gastroenterol Hepatol | Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function. | 2018 | Details |
| A12987 | 30194936 | Eur J Pharmacol | Sparstolonin B (SsnB) attenuates liver fibrosis via a parallel conjugate pathway involving P53-P21 axis, TGF-beta signaling and focal adhesion that is TLR4 dependent. | 2018 | Details |
| A12988 | 30194708 | Aliment Pharmacol Ther | Review article: drug-induced liver injury in the context of nonalcoholic fatty liver disease - a physiopathological and clinical integrated view. | 2018 | Details |
| A12990 | 30193922 | J Hepatol | Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia. | 2018 | Details |
| A12991 | 30193066 | J Agric Food Chem | Insecticide Exposure and Development of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12992 | 30192782 | PLoS One | Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial. | 2018 | Details |
| A12993 | 30191499 | Dig Dis Sci | Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway. | 2018 | Details |
| A12994 | 30191231 | Analyst | Rapid diagnostics of liver steatosis by Raman spectroscopy via fiber optic probe: a pilot study. | 2018 | Details |
| A12995 | 30190781 | World J Hepatol | Current status of imaging in nonalcoholic fatty liver disease. | 2018 | Details |
| A12996 | 30190738 | Pak J Med Sci | Association of serum liver enzyme Alanine Aminotransferase (ALT) in patients with type 2 diabetes. | 2022 | Details |
| A12997 | 30189154 | Appl Physiol Nutr Metab | Camellia oleifera seed extract attenuated abdominal and hepatic fat accumulation in rats fed a high-fat diet. | 2018 | Details |
| A12998 | 30188729 | Mol Pharm | Polyurethane Nanoparticle-Loaded Fenofibrate Exerts Inhibitory Effects on Nonalcoholic Fatty Liver Disease in Mice. | 2018 | Details |
| A12999 | 30188604 | Liver Int | Positive familial history for metabolic traits predisposes to early and more severe alcoholic cirrhosis: A cross-sectional study. | 2018 | Details |
| A13000 | 30187493 | J Sci Food Agric | Mango phenolics increase the serum apolipoprotein A1/B ratio in rats fed high cholesterol and sodium cholate diets. | 2018 | Details |
| A13001 | 30186875 | J Diabetes Res | Enhancement of Adiponectin Ameliorates Nonalcoholic Fatty Liver Disease via Inhibition of FoxO1 in Type I Diabetic Rats. | 2018 | Details |
| A13002 | 30186546 | Oxid Med Cell Longev | Corrigendum to "Circulating Levels of Sirtuin 4, a Potential Marker of Oxidative Metabolism, Related to Coronary Artery Disease in Obese Patients Suffering from NAFLD, with Normal or Slightly Increased Liver Enzymes". | 2018 | Details |
| A13003 | 30186230 | Front Endocrinol (Lausanne) | Succinate as a Regulator of Hepatic Stellate Cells in Liver Fibrosis. | 2018 | Details |
| A13004 | 30185840 | Eur J Clin Nutr | Body composition and insulin resistance in children. | 2018 | Details |
| A13005 | 30185127 | Biosci Biotechnol Biochem | Marginal iron deficiency enhances liver triglyceride accumulation in rats fed a high-sucrose diet. | 2018 | Details |
| A13006 | 30185098 | J Int Med Res | Clinical relevance of reporting fatty liver on ultrasound in asymptomatic patients during routine health checkups. | 2018 | Details |
| A13007 | 30183584 | Chirurgia (Bucur) | The Role of Beta-7 Integrin and Carbonic Anhydrase IX in Predicting the Occurrence of de Novo Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. | 2019 | Details |
| A13008 | 30183204 | Neuro Endocrinol Lett | Rapidly progressive non-alcoholic fatty liver disease due to hypopituitarism. Report of 5 cases. | 2018 | Details |
| A13009 | 30183139 | Mol Nutr Food Res | Gamma-Tocotrienol Attenuates the Hepatic Inflammation and Fibrosis by Suppressing Endoplasmic Reticulum Stress in Mice. | 2018 | Details |
| A13010 | 30182761 | Endocr Res | A subset of patients with acquired partial lipodystrophy developing severe metabolic abnormalities. | 2018 | Details |
| A13011 | 30182166 | Hepatol Int | Serum ferritin level is associated with liver steatosis and fibrosis in Korean general population. | 2018 | Details |
| A13012 | 30181611 | Nat Rev Gastroenterol Hepatol | Gut adaptation after metabolic surgery and its influences on the brain, liver and cancer. | 2018 | Details |
| A13013 | 30180767 | Am J Chin Med | Gypenoside UL4-Rich Gynostemma pentaphyllum Extract Exerts a Hepatoprotective Effect on Diet-Induced Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13014 | 30180301 | Basic Clin Pharmacol Toxicol | Protective effect of isochlorogenic acid B on liver fibrosis in non-alcoholic steatohepatitis of mice. | 2018 | Details |
| A13015 | 30180285 | Hepatology | Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States. | 2019 | Details |
| A13016 | 30180152 | J Clin Gastroenterol | Pretransplant Sarcopenia in Patients With NASH Cirrhosis Does Not Impact Rehospitalization or Mortality. | 2019 | Details |
| A13017 | 30179294 | Liver Int | Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring. | 2018 | Details |
| A13018 | 30179269 | Hepatology | Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2019 | Details |
| A13019 | 30179227 | Eur J Gastroenterol Hepatol | Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma. | 2018 | Details |
| A13020 | 30178600 | Diabetes Obes Metab | Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease. | 2018 | Details |
| A13021 | 30178233 | Front Med | Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota. | 2018 | Details |
| A13022 | 30176941 | J Nanobiotechnology | Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD. | 2018 | Details |
| A13023 | 30176114 | Liver Int | Relationship between non-alcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents. | 2018 | Details |
| A13024 | 30175608 | Orv Hetil | [The role of gut microbiota in chronic liver diseases, and treatment possibilities]. | 2018 | Details |
| A13026 | 30175257 | Anim Nutr | Inhibitory effect of blue honeysuckle extract on high-fat-diet-induced fatty liver in mice. | 2018 | Details |
| A13027 | 30174482 | Korean J Radiol | Correlation between Non-Alcoholic Fatty Liver Disease and Visceral Adipose Tissue in Non-Obese Chinese Adults: A CT Evaluation. | 2018 | Details |
| A13028 | 30174213 | Lancet Diabetes Endocrinol | Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. | 2018 | Details |
| A13029 | 30173562 | Expert Opin Biol Ther | Fecal microbiota transplantation: a promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response. | 2018 | Details |
| A13031 | 30172659 | Clin Nutr | Marine omega-3 fatty acid supplementation in non-alcoholic fatty liver disease: Plasma proteomics in the randomized WELCOME* trial. | 2018 | Details |
| A13032 | 30172252 | Lipids Health Dis | Exercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits. | 2018 | Details |
| A13033 | 30171810 | Horm Mol Biol Clin Investig | Metalloproteinases in non-alcoholic fatty liver disease and their behavior in liver fibrosis. | 2018 | Details |
| A13034 | 30171718 | J Cell Biochem | PNPLA3 variant M148 causes resistance to starvation-mediated lipid droplet autophagy in human hepatocytes. | 2018 | Details |
| A13035 | 30171159 | Mol Cell Proteomics | Hepatic Mitochondrial Defects in a Nonalcoholic Fatty Liver Disease Mouse Model Are Associated with Increased Degradation of Oxidative Phosphorylation Subunits. | 2018 | Details |
| A13036 | 30171065 | Gut | Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease. | 2018 | Details |
| A13037 | 30171034 | Dis Model Mech | Idebenone and coenzyme Q10 are novel PPARα/γ ligands, with potential for treatment of fatty liver diseases. | 2018 | Details |
| A13038 | 30170429 | Medicine (Baltimore) | Non-alcoholic fatty liver disease and the risk of urolithiasis: A systematic review and meta-analysis. | 2018 | Details |
| A13039 | 30170304 | Nutrition | Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: A randomized clinical trial. | 2018 | Details |
| A13040 | 30170220 | Atherosclerosis | Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease. | 2018 | Details |
| A13041 | 30170074 | Diabetes Res Clin Pract | Non-alcoholic fatty liver disease: Relationship with cardiovascular risk markers and clinical endpoints. | 2018 | Details |
| A13042 | 30168806 | J Clin Invest | Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease. | 2018 | Details |
| A13043 | 30166956 | Gastroenterol Hepatol (N Y) | Overview of Updated Practice Guidelines for Pediatric Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13044 | 30166861 | World J Gastroenterol | C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population. | 2018 | Details |
| A13045 | 30166857 | World J Gastroenterol | Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis. | 2018 | Details |
| A13046 | 30166633 | Am J Gastroenterol | Alcohol Consumption in Patients with Non-alcoholic Fatty Liver Disease: Convenient vs. Inconvenient Truths. | 2018 | Details |
| A13047 | 30166404 | Drug Metab Dispos | Gene-by-Environment Interaction of Bcrp-/- and Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Steatohepatitis Alters SN-38 Disposition. | 2018 | Details |
| A13048 | 30165848 | BMC Complement Altern Med | Comparison of the main components and bioactivity of Rhus verniciflua Stokes extracts by different detoxification processing methods. | 2018 | Details |
| A13049 | 31807367 | Liver Res | Regulation of the homeostasis of hepatic endoplasmic reticulum and cytochrome P450 enzymes by autophagy. | 2018 | Details |
| A13050 | 30161179 | PLoS One | Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis. | 2018 | Details |
| A13051 | 30161167 | PLoS One | PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC. | 2018 | Details |
| A13052 | 30160786 | J Gastroenterol Hepatol | Caspase-independent hepatocyte death: A result of the decrease of lysophosphatidylcholine acyltransferase 3 in non-alcoholic steatohepatitis. | 2018 | Details |
| A13055 | 30160281 | Food Funct | Freshwater clam extract reduces liver injury by lowering cholesterol accumulation, improving dysregulated cholesterol synthesis and alleviating inflammation in high-fat, high-cholesterol and cholic acid diet-induced steatohepatitis in mice. | 2018 | Details |
| A13056 | 30158971 | Gastroenterol Res Pract | Establishment and Comparison of Juvenile Female Mouse Models of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2018 | Details |
| A13058 | 30158570 | Nat Rev Gastroenterol Hepatol | The changing epidemiology of liver diseases in the Asia-Pacific region. | 2019 | Details |
| A13059 | 30158201 | J Lipid Res | Extrahepatic PPARα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice. | 2018 | Details |
| A13065 | 30154499 | Sci Rep | The PPARα Agonist Fenofibrate Prevents Formation of Protein Aggregates (Mallory-Denk bodies) in a Murine Model of Steatohepatitis-like Hepatotoxicity. | 2018 | Details |
| A13066 | 30154417 | Cell Death Dis | JAZF1 ameliorates age and diet-associated hepatic steatosis through SREBP-1c -dependent mechanism. | 2018 | Details |
| A13067 | 30154382 | Int J Mol Sci | Flavonones from Penthorum chinense Ameliorate Hepatic Steatosis by Activating the SIRT1/AMPK Pathway in HepG2 Cells. | 2018 | Details |
| A13069 | 30153476 | Free Radic Biol Med | Molecular mechanisms related to the hepatoprotective effects of antioxidant-rich extra virgin olive oil supplementation in rats subjected to short-term iron administration. | 2018 | Details |
| A13070 | 30153225 | Transplantation | International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation. | 2019 | Details |
| A13072 | 30151008 | Int J Endocrinol | The Combined Effect of Nonalcoholic Fatty Liver Disease and Metabolic Syndrome on Osteoporosis in Postmenopausal Females in Eastern China. | 2018 | Details |
| A13073 | 30150602 | Molecules | Deoxyschizandrin Loaded Liposomes on the Suppression Lipid Accumulation in 3T3-L1 Adipocytes. | 2018 | Details |
| A13074 | 30149902 | Pathol Res Pract | Serum CK 18-M30 reflect liver pathological severity during NAFLD progression in a rat model. | 2018 | Details |
| A13075 | 30149145 | Diabetes Metab | SGLT2 inhibitors and incretin agents: Associations with alanine aminotransferase activity in type 2 diabetes. | 2018 | Details |
| A13076 | 30148144 | World J Clin Cases | PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease. | 2018 | Details |
| A13077 | 30147834 | Oxid Med Cell Longev | Possible Involvement of Mitochondrial Dysfunction and Oxidative Stress in a Cellular Model of NAFLD Progression Induced by Benzo[a]pyrene/Ethanol CoExposure. | 2018 | Details |
| A13078 | 30146425 | Surg Obes Relat Dis | Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score). | 2018 | Details |
| A13079 | 30145577 | Ann Hepatol | Salidroside and Curcumin Formula Prevents Liver Injury in Nonalcoholic Fatty Liver Disease in Rats. | 2018 | Details |
| A13080 | 30145572 | Ann Hepatol | Fast Morphological Gallbladder Changes Triggered by a Hypercholesterolemic Diet. | 2018 | Details |
| A13081 | 30145565 | Ann Hepatol | Thyroid Function and Risk of Non-Alcoholic Fatty Liver Disease in Euthyroid Subjects. | 2018 | Details |
| A13082 | 30144554 | J Hepatol | The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options. | 2018 | Details |
| A13083 | 30144434 | Gastroenterology | Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A13084 | 30144360 | J Gastroenterol Hepatol | Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients. | 2018 | Details |
| A13085 | 30143610 | Nat Commun | Loss of the E3 ubiquitin ligase MKRN1 represses diet-induced metabolic syndrome through AMPK activation. | 2018 | Details |
| A13086 | 30143402 | Acad Radiol | Noninvasive Differential Diagnosis of Liver Iron Contents in Nonalcoholic Steatohepatitis and Simple Steatosis Using Multiecho Dixon Magnetic Resonance Imaging. | 2018 | Details |
| A13089 | 30142943 | Nutrients | Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence. | 2018 | Details |
| A13090 | 30142454 | Free Radic Biol Med | Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state. | 2018 | Details |